Valneva SE (VALN) EBITDA Margin (2021 - 2026)

Valneva SE's (VALN) quarterly EBITDA Margin came in at 59.64% in Q1 2026, down 5840.0% year-on-year from 1.04% in Q1 2025, and down 5.81% quarter-over-quarter from 56.36% in Q4 2025.

Valneva SE (VALN) EBITDA Margin (2021 - 2026) Analysis & Trends

Valneva SE has disclosed EBITDA Margin across 6 years of filings, most recently posting 59.64% for Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 59.64%, down 5840.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 55.48% (down 3275.0% YoY), and the FY2025 annual result was 37.62%, down 5777.0% from the prior year.
  • EBITDA Margin came in at 59.64% for Q1 2026 at Valneva SE, down from 56.36% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 93862.2% in Q4 2022 to a low of 92077.59% in Q3 2022.
  • The 5-year median for EBITDA Margin is 42.58% (2023), against an average of 41.59%.
  • Across the five-year window, EBITDA Margin soared 9285613 bps in 2022 and plunged 9390255 bps in 2023, its largest moves.
  • Valneva SE's EBITDA Margin stood at 93862.2% in 2022, then plunged by 100 bps to 40.35% in 2023, then gained by 23 bps to 30.91% in 2024, then sank by 82 bps to 56.36% in 2025, then dropped by 6 bps to 59.64% in 2026.
  • The last three EBITDA Margin figures came in at 59.64% (Q1 2026), 56.36% (Q4 2025), and 111.7% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 38.10%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -59.64%

Historic Data

Download Data
DateValue
Mar 31, 2026 -59.64%
Dec 31, 2025 -56.36%
Sep 30, 2025 -111.70%
Jun 30, 2025 -12.73%
Mar 31, 2025 -1.23%
Dec 31, 2024 -30.91%
Sep 30, 2024 -17.19%
Jun 30, 2024 -46.50%
Mar 31, 2024 227.07%
Dec 31, 2023 -40.35%
Sep 30, 2023 -48.55%
Jun 30, 2023 -42.58%
Mar 31, 2023 -38.32%
Dec 31, 2022 93,862.20%
Sep 30, 2022 -92,077.59%
Jun 30, 2022 -684.80%
Mar 31, 2022 -113.85%
Dec 31, 2021 1,006.07%
Sep 30, 2021 -1,104.77%
Jun 30, 2021 -331.24%